Real-time enrollment status for this scleroderma clinical trial
Current Status
Recruiting
Checked: March 2, 2026 at 7:19 AM UTC
| NCT Number | NCT06655896 |
| Recruiting Status | Recruiting |
| Condition | Scleroderma |
| Phase | Clinical Trial |
| Target Enrollment | 86 participants |
| Active Locations | 7 sites in the US |
| Sponsor | Novartis Pharmaceuticals |
| Last Updated on CT.gov | February 20, 2026 (1 week ago) |
As of March 2, 2026: Clinical trial NCT06655896 is currently recruiting participants. This clinical trial study for scleroderma is actively seeking new participants at 7 locations across the United States. The study is sponsored by Novartis Pharmaceuticals. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06655896 is actively recruiting participants as of March 2, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 7 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06655896 was last updated 1 week ago (February 20, 2026). HelloStudys verifies this status automatically.